DNA damage induces BRCA1 distribution alteration in prostate cancer cell lines.
- Author:
Chun-Yang WANG
1
;
Sheng-Kun SUN
;
Wei-Jun FU
;
Tao SONG
;
Wei CAI
;
Jiang-Ping GAO
;
Bao-Fa HONG
;
Xiao-Xiong WANG
;
Hong WANG
Author Information
- Publication Type:Journal Article
- MeSH: BRCA1 Protein; metabolism; Blotting, Western; Cell Line, Tumor; DNA Damage; Humans; Immunohistochemistry; Male; Prostatic Neoplasms; genetics; metabolism; pathology; Tumor Suppressor Protein p53; metabolism
- From: National Journal of Andrology 2008;14(8):685-689
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the role of the tumor suppressor gene BRCA1 in response to DNA damage and to confirm that the function of the BRCA1 protein is regulated by a variety of mechanisms including transcriptional control, phosphorylation and protein-protein interaction.
METHODSWith the human breast cell line MCF7 as the positive control, we determined the subcellular distribution of BRCA1 in the prostate cancer cell lines LNCaP, DU145 and PC3 by immunohistochemical staining and Western blotting analyses.
RESULTSBRCA1 was present in the prostate cancer cell lines LNCaP, DU145 and PC3. Ionizing radiation induced BRCA1 nuclear export, increasing from 14% to 40% in the cytoplasma (P < 0.01) and decreasing from 46% to 21% in the nuclei (P < 0.01). This DNA damage-induced BRCA1 nuclear export occurred only in the p53 wild-type but not in the p53 mutant cell line. The apoptosis rate of LNCaP cells was as high as 40% after nuclear export, with an obvious increase of cleaved caspase-3, which was correlated with BRCA1 nuclear-cytoplasmic shuttling.
CONCLUSIONCytoplasmic relocalization of the BRCA1 protein may be a mechanism whereby the BRCA1 function is regulated in response to DNA damage. Its induction of a higher rate of cell apoptosis indicates BRCA1 to be another good biomarker for the treatment of prostate cancer.